ClinicalTrials.Veeva

Menu

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility

Sanofi logo

Sanofi

Status and phase

Completed
Phase 3

Conditions

Hygiene

Treatments

Drug: Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)

Study type

Interventional

Funder types

Industry

Identifiers

NCT00784160
LACAC_L_04308

Details and patient eligibility

About

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDETINBACK Tangerine Mix (Lactic Acid).

Enrollment

53 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 18 and 60 years old;
  • Phototype Skin I,II, III e IV;
  • Integral skin test in the region;
  • Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria

  • Lactation or gestation;
  • Personnel history of atopy;
  • History of sensitivity or irritation for topic products;
  • Active cutaneous disease;
  • Use of new drugs or cosmetics during the study;

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

53 participants in 1 patient group

1
Experimental group
Description:
Lactic Acid
Treatment:
Drug: Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems